These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11408945)

  • 1. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms.
    Matsumoto Y; Ishiko O; Deguchi M; Nakagawa E; Ogita S
    Int J Mol Med; 2001 Jul; 8(1):31-6. PubMed ID: 11408945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
    Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN
    Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.
    Kim MH; Seo SS; Song YS; Kang DH; Park IA; Kang SB; Lee HP
    Gynecol Oncol; 2003 Jul; 90(1):83-90. PubMed ID: 12821346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.
    Joo YE; Rew JS; Seo YH; Choi SK; Kim YJ; Park CS; Kim SJ
    J Clin Gastroenterol; 2003 Jul; 37(1):28-33. PubMed ID: 12811205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
    Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
    Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
    Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
    Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
    Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
    Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
    J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase.
    Fujiwaki R; Iida K; Kanasaki H; Ozaki T; Hata K; Miyazaki K
    Hum Pathol; 2002 Feb; 33(2):213-9. PubMed ID: 11957147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
    Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression in borderline ovarian tumors.
    Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
    Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 and angiogenesis in gastric cancer.
    Walther Z
    J Clin Gastroenterol; 2003 Jul; 37(1):4-6. PubMed ID: 12811200
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
    Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
    Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colon cancer and COX-2].
    Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
    [No Abstract]   [Full Text] [Related]  

  • 17. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase 2 expression in serous tumors of the ovary.
    Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
    Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.
    Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR
    Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma.
    Jaeckel EC; Raja S; Tan J; Das SK; Dey SK; Girod DA; Tsue TT; Sanford TR
    Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1253-9. PubMed ID: 11587608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.